Pfizer is no stranger to victories in the fight against the coronavirus. The pharmaceutical behemoth marked its first significant victory last December when the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for its vaccine. This made Pfizer the first company to bring the COVID-19 vaccine to market.
Our Analysis:
As long as the price is above 45.30, follow the recommendations below:
- Time frame: D1
- Recommendation: long position
- Entry point: 47.38
- Take Profit 1: 51.20
- Take Profit 2: 52.70
Alternative scenario:
If the level of 45.30 is broken-down, follow the recommendations below:
- Time frame: D1
- Recommendation: short position
- Entry point: 45.30
- Take Profit 1: 42.90
- Take Profit 2: 41.30
No comments:
Post a Comment